Common vaccine linked to 24% lower dementia risk in older adults
A Brown University study found Shingrix reduced dementia risk by 24% over four years, building on prior research linking the shingles vaccine to brain health.
Useful takeaways from this story.
A Brown University study found Shingrix reduced dementia risk by 24% over four years, building on prior research linking the shingles vaccine to brain health.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
A Brown University study found Shingrix reduced dementia risk by 24% over four years, building on prior research linking the shingles vaccine to brain health.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.